IGF-1 LR3 – 1mg research peptide. 

igf-1 lr3 1mg research peptide uk — supplied as a high-purity lyophilized powder for laboratory research use only. Each vial is independently verified through third-party analytical testing (COA available) to confirm purity and identity. This material is intended exclusively for qualified researchers working in controlled laboratory environments.

IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a synthetic peptide analog of human IGF-1. It has been modified to extend its half-life and reduce binding to IGF-binding proteins, enhancing its stability in laboratory experiments. Research often investigates its role in cellular proliferation, differentiation, and survival across various biological models.

Preclinical studies of igf-1 lr3 1mg research peptide uk include models focused on muscle growth, tissue repair, and metabolic regulation. Laboratory investigations also examine its potential effects on glucose handling, protein synthesis pathways, and anabolic signaling. These studies remain strictly experimental and are not intended for therapeutic applications.

This peptide is not for human or veterinary use and must not be applied in diagnostic or clinical settings. Researchers are advised to handle vials with appropriate protective equipment, reconstitute only with sterile solvents, and store under recommended laboratory conditions.

This listing provides igf-1 lr3 1mg research peptide uk with COA; supplied for research use only; not for human or veterinary consumption; UK supply available only to qualified laboratories.